Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Key Market Size Shifts in the Neurotrophic Keratitis Treatment Market: A Historical Perspective and beyond
The market size for the treatment of neurotrophic keratitis has seen a considerable upsurge in the recent past. It is expected to rise from $1.08 billion in 2024 to $1.47 billion in 2025, recording a compound annual growth rate (CAGR) of 36.3%. The impressive growth during the historic period can be credited to factors such as elevated diagnostic rates, an increase in injuries and surgical procedures, escalated research and development efforts, and the global improvement in healthcare infrastructure.
The market for treatment of neurotrophic keratitis is predicted to witness substantial growth in the coming years, with a projected value of $4.99 billion by 2029, and a compound annual growth rate (CAGR) of 35.9%. This market expansion in the forecast period can be accredited to factors such as the rise in educational campaigns, increase in clinical trials, advanced treatment methods, and regulatory authorizations. Key trends expected during this forecast period comprise the enhancement of diagnostic instruments, the application of digital health solutions, strategies for neuroprotection, and the advancement of ocular surface imaging.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
Key Drivers Behind the Expansion of the Neurotrophic Keratitis Treatment Market: Insights and Trends
The escalating incidence of ocular disorders has been projected to fuel the expansion of the neurotrophic keratitis treatment market in the forthcoming period. Eye disorders comprise an assortment of health anomalies which impair normal vision and eye functionality. Neurotrophic keratitis plays a key role in enhancing corneal sensation, hastening healing, preventing infections, and providing relief from pain. For instance, data released by Eye Care One, an American eyecare career services platform, in March 2022 pointed to an estimated 35 million Americans being affected by dry eye disease (DED) that year, with this number expected to increase annually.
Furthermore, in May 2024, the U.S. Centers for Disease Control and Prevention, a government agency belonging to the Department of Health and Human Services, indicated that more than 3.4 million American individuals aged 40 and above either suffer from blindness or visual impairment. This number is anticipated to double by 2030. Consequently, the rising incidence of eye disorders is spurring the growth of the neurotrophic keratitis treatment market.
Which Segments in the Neurotrophic Keratitis Treatment Industry Are Seeing the Fastest Growth?
The neurotrophic keratitis treatmentmarket covered in this report is segmented –
1) By Treatment: Topical Antibiotics; Recombinant Human Nerve Growth Factor (rhNGF); Amniotic Membrane Transplantation; Keratoplasty; Other Treatments
2) By Route of Administration: Oral; Topical; Other Routes of Administration
3) By Application: Stage I; Stage II; Stage III
4) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users
Subsegments:
1) By Topical Antibiotics: Broad-Spectrum Antibiotics; Narrow-Spectrum Antibiotics
2) By Recombinant Human Nerve Growth Factor (rhNGF): Cenegermin Ophthalmic Solution; Other rhNGF-Based Solutions
3) By Amniotic Membrane Transplantation: Cryopreserved Amniotic Membrane; Dehydrated Amniotic Membrane
4) By Keratoplasty: Penetrating Keratoplasty; Lamellar Keratoplasty
5) By Other Treatments: Tarsorrhaphy; Therapeutic Contact Lenses
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
Which New Trends Will Create Growth Opportunities in the Neurotrophic Keratitis Treatment Market?
Leading firms in the neurotrophic keratitis treatment industry are focusing on the invention of novel drugs and their approval to strengthen their place in the market. The creation of these new drugs is crucial in this field, as there is a scarcity of effective current treatments and a high demand for more potent means to halt the advancement of the disease. For example, BRIM Biotechnology Inc., a clinical-stage corporation based in Taiwan, was granted the Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) in December 2022, for the use of BRM424 in dealing with neurotrophic keratitis (NK). BRM424 is a recombinant type of human nerve growth inducer, which encourages both growth and modification of corneal limbal stem cells to stimulate regeneration and improve the health of the cornea in patients suffering from neurotrophic keratitis.
Which Global Regions Are Powering Demand in the Neurotrophic Keratitis Treatment Market?
North America was the largest region in the neurotrophic keratitis treatment market in 2024. The regions covered in neurotrophic keratitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
How Key Players Are Driving Growth in the Neurotrophic Keratitis Treatment Market?
Major companies operating in the neurotrophic keratitis treatment market are Eyevance Pharmaceuticals LLC, Grand Pharma Co. Ltd., Walgreen Co., Pfizer Inc., Johnson and Johnson, Bayer AG, Novartis AG, Abbott Laboratories, Gilead Biosciences Inc., Merck and Co. Inc., Allergan Inc., Alcon Inc., Bausch Health Companies Inc., Bausch & Lomb Inc., CooperVision Inc., Rohto Pharmaceutical Co. Ltd., Santen Pharmaceutical Co. Ltd., Zhejiang Conba Pharmaceutical Co. Ltd., Glenmark Pharmaceuticals Limited, Dompe farmaceutici S.p.A, Aurolab, Ocular Therapeutix Inc., Laboratoires Thea SAS, Leadiant Biosciences Inc., ReGenTree LLC, Contacare Opthalmic Private Limited, Neuroptika Inc., Surgitech Innovation Private Limited.
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=12968
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
